←Back to Expert Scholars
Translational Medicine / 转化医学mRNA Vaccine Design, CTA Antigens
Sebastian Kreiter
MD
🏢BioNTech🌐Germany
Chief Development Officer
60
h-index
0
Key Papers
0
Key Contributions
👥Biography 个人简介
Sebastian Kreiter at BioNTech has led mRNA cancer vaccine design and clinical translation for cancer-testis antigen and personalized neoantigen targets. His work spans both shared antigen (CTA) and individualized neoantigen mRNA platforms now in pivotal trials.
Share:
🧪Research Fields 研究领域
mRNA vaccine design
personalized cancer vaccine
MAGE vaccine
antigen selection
clinical translation
🎓Key Contributions 主要贡献
Representative Works 代表性著作
📄Data Sources 数据来源
Last updated: 2026-04-01 | All information from publicly available academic sources
Related Experts 相关专家
Antoni Ribas
UCLA Jonsson Comprehensive Cancer Center
Melanoma ImmunotherapyCheckpoint Inhibitors
Drew M. Pardoll
Johns Hopkins University
Cancer ImmunologyPD-1/PD-L1 Pathway
Padmanee Sharma
MD Anderson Cancer Center
Bladder Cancer ImmunotherapyImmune Profiling
Naiyer A. Rizvi
Columbia University Irving Medical Center
Lung Cancer ImmunotherapyTumor Mutational Burden
关注 Sebastian Kreiter 的研究动态
Follow Sebastian Kreiter's research updates
留下邮箱，当我们发布与 Sebastian Kreiter（BioNTech）相关的新研究或访谈时，我们会通知你。
Explore More Experts
Discover the researchers shaping the future of cancer treatment